Pure Global AI
NCT06383494Recruiting

GMA-TulipTM, i-gelTM and the LMA-SupremeTM (LMA-S) Devices in Airway Management

GMA-TulipTM, i-gelTM and the LMA-SupremeTM (LMA-S) Devices in Airway Management Under General Anesthesia, a Randomized Controlled Study
Zhejiang Cancer HospitalClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Anesthesia
Drug/Device/Intervention
LMA supreme group
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Zhejiang Cancer Hospital
Location
Hangzhou, China
Timeline & enrollment
Phase
N/A
Start date
Apr 30, 2024
End date
Dec 30, 2025
Enrollment
276 participants
Primary outcome

Glottic exposure grading

Summary

Patients were randomly assigned to three extraglottic airway (EGA) devices groups for airway
 management after anesthesia induced. Fiberoptic bronchoscope (FB) guided glottic exposure
 grading was performed and other airway management quality was recorded.

ICD-10 classifications
Anaesthetic, unspecifiedOther and unspecified general anaestheticsLocal anaestheticsOther complications of anaesthesiaComplication of anaesthesia during labour and delivery, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06383494
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06383494 through Pure Global AI's free database. This phase not specified trial is sponsored by Zhejiang Cancer Hospital and is currently Recruiting. The study focuses on Anesthesia. Target enrollment is 276 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.